Preventive use of beta-blockers for anthracycline-induced cardiotoxicity: a network meta-analysis
D He, J Hu, Y Li, X Zeng - Frontiers in Cardiovascular Medicine, 2022 - frontiersin.org
Background Anthracyclines are commonly used chemotherapeutic agents to treat malignant
tumors. However, cardiotoxicity is a potentially serious adverse effect of anthracyclines. Beta …
tumors. However, cardiotoxicity is a potentially serious adverse effect of anthracyclines. Beta …
The behavioral model and game theory
The rational choice theory is based on this idea that people rationally pursue goals for
increasing their personal interests. Here, we present a new concept of rational choice as a …
increasing their personal interests. Here, we present a new concept of rational choice as a …
Overview of antagonists used for determining the mechanisms of action employed by potential vasodilators with their suggested signaling pathways
This paper is a review on the types of antagonists and the signaling mechanism pathways
that have been used to determine the mechanisms of action employed for vasodilation by …
that have been used to determine the mechanisms of action employed for vasodilation by …
Short‐and long‐term administration of imeglimin counters cardiorenal dysfunction in a rat model of metabolic syndrome
M Lachaux, M Soulié, M Hamzaoui… - Endocrinology …, 2020 - Wiley Online Library
Introduction Imeglimin, a glucose‐lowering agent targeting mitochondrial bioenergetics,
decreases reactive oxygen species (ROS) overproduction and improves glucose …
decreases reactive oxygen species (ROS) overproduction and improves glucose …
Benefits of the non-steroidal mineralocorticoid receptor antagonist finerenone in metabolic syndrome-related heart failure with preserved ejection fraction
I Lima-Posada, Y Stephan, M Soulié… - International Journal of …, 2023 - mdpi.com
The mineralocorticoid receptor (MR) plays an important role in the development of chronic
kidney disease (CKD) and associated cardiovascular complications. Antagonizing the …
kidney disease (CKD) and associated cardiovascular complications. Antagonizing the …
Soluble epoxide hydrolase inhibition improves myocardial perfusion and function in experimental heart failure
N Merabet, J Bellien, E Glevarec, L Nicol… - Journal of molecular and …, 2012 - Elsevier
The study addressed the hypothesis that soluble epoxide hydrolase (sEH) inhibition, which
increases cardiovascular protective epoxyeicosatrienoic acids (EETs), exerts beneficial …
increases cardiovascular protective epoxyeicosatrienoic acids (EETs), exerts beneficial …
Short‐and long‐term administration of the non‐steroidal mineralocorticoid receptor antagonist finerenone opposes metabolic syndrome‐related cardio‐renal …
M Lachaux, J Barrera‐Chimal, L Nicol… - Diabetes, Obesity …, 2018 - Wiley Online Library
Aim To determine whether non‐steroidal mineralocorticoid receptor (MR) antagonists
oppose metabolic syndrome‐related end‐organ, ie cardiac, damage. Materials and methods …
oppose metabolic syndrome‐related end‐organ, ie cardiac, damage. Materials and methods …
Heart rate reduction induced by the if current inhibitor ivabradine improves diastolic function and attenuates cardiac tissue hypoxia
Y Fang, M Debunne, M Vercauteren… - Journal of …, 2012 - journals.lww.com
Aims Enhanced heart rate (HR) is a compensatory mechanism in chronic heart failure
(CHF), preserving cardiac output, but at the cost of increased left ventricular (LV) oxygen …
(CHF), preserving cardiac output, but at the cost of increased left ventricular (LV) oxygen …
Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the transgenic (mRen2) rat
Angiotensin II contributes to myocardial tissue remodeling and interstitial fibrosis through
NADPH oxidase-mediated generation of oxidative stress in the progression of heart failure …
NADPH oxidase-mediated generation of oxidative stress in the progression of heart failure …
Enhanced angiogenesis and increased cardiac perfusion after myocardial infarction in protein tyrosine phosphatase 1B‐deficient mice
M Besnier, A Galaup, L Nicol, JP Henry… - The FASEB …, 2014 - Wiley Online Library
The protein tyrosine phosphatase 1B (PTP1B) modulates tyrosine kinase receptors, among
which is the vascular endothelial growth factor receptor type 2 (VEGFR2), a key component …
which is the vascular endothelial growth factor receptor type 2 (VEGFR2), a key component …